% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

atlnsider 2 posts  |  Last Activity: Nov 24, 2015 6:02 PM Member since: Dec 6, 2003
  • atlnsider atlnsider Nov 24, 2015 6:02 PM Flag

    That's an improvement in OS of 13.8 months, or an increase of 58% longer than the Control group.

    I am hoping that with the changes in the Phase 3 trial, the OS & PFS differences between the ICT-107 group and the Control group, will be even more dramatic & pronounced. The changes in the Phase 3 trial include:

    1. More doses of ICT-107 for the treatment group.
    2. Treat only HLA-A2+ patients only
    3. Treat the control group with monocytes only, and not any dendritic cells

    Sentiment: Strong Buy

  • Reply to

    Price blip.

    by bawmah Nov 23, 2015 4:05 PM
    atlnsider atlnsider Nov 23, 2015 6:06 PM Flag

    I have not seen any pumping of OPXA recently. Can you tell me where the pumping is, or provide me with a link?

    Thanks in advance...

    Sentiment: Strong Buy

1.38+0.02(+1.47%)Nov 27 1:00 PMEST